The barcode 300060267024 corresponds to Rizatriptan, marketed under the brand name Maxalt, which is used primarily for the treatment of migraine headaches. Rizatriptan is a medication classified as a triptan, which selectively targets serotonin receptors in the brain to alleviate migraine symptoms.
Formulation and Dosage:
Prices:
Allergic Reactions: Some individuals may experience allergies, leading to symptoms such as skin rash, itching, or difficulty breathing.
Cardiovascular Risks: There is a potential for increased blood pressure and heart rate, which necessitates caution in individuals with existing cardiovascular conditions.
Side Effects: Common side effects include dizziness, drowsiness, and lightheadedness due to the effects it has on blood vessels.
Withdrawal Headache: Abrupt cessation or reduction of the medication may lead to withdrawal headaches.
There is no specific health-related disclaimer notice associated with Rizatriptan (Maxalt) as it is a prescription medication. However, it is essential to use it under the guidance of a healthcare professional to ensure safety and efficacy for an individual's health conditions. Always consult with a healthcare provider for personalized advice, particularly regarding proper use and potential interactions with other medications.
| 出典: | |
|---|---|
| 製造者コード: | |
| 製品コード: |
この製品情報は役に立ちましたか?
この製品をおすすめしますか?